PT Kalbe Farma Tbk.
General ticker "PTKFF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - General
- Capitalization: $3.8B (TTM average)
PT Kalbe Farma Tbk. does not follow the US Stock Market performance with the rate: -5.4%.
Estimated limits based on current volatility of 0.0%: low 0.08$, high 0.08$
Factors to consider:
- Company pays dividends (annually): last record date 2025-06-05, amount 0.00$ (Y0.00%)
Short-term PTKFF quotes
Long-term PTKFF plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 |
|---|---|---|
| Operating Revenue | IDR30,449,134.08MM | IDR32,627,776.11MM |
| Operating Expenses | IDR26,818,297.56MM | IDR28,560,329.75MM |
| Operating Income | IDR3,630,836.52MM | IDR4,067,446.35MM |
| Non-Operating Income | IDR-24,599.31MM | IDR151,427.92MM |
| Interest Expense | IDR95,103.84MM | IDR56,320.23MM |
| R&D Expense | IDR329,621.04MM | IDR471,599.96MM |
| Income(Loss) | IDR3,606,237.20MM | IDR4,218,874.27MM |
| Taxes | IDR827,832.38MM | IDR972,304.52MM |
| Profit(Loss)* | IDR2,766,748.04MM | IDR3,240,636.63MM |
| Stockholders Equity | IDR21,418,856.50MM | IDR22,788,879.43MM |
| Inventory | IDR6,791,979.79MM | IDR6,501,631.20MM |
| Assets | IDR27,057,568.18MM | IDR29,429,727.90MM |
| Operating Cash Flow | IDR2,907,475.17MM | IDR4,785,179.04MM |
| Capital expenditure | IDR1,178,972.22MM | IDR1,250,335.29MM |
| Investing Cash Flow | IDR-1,140,786.69MM | IDR-1,247,287.97MM |
| Financing Cash Flow | IDR-2,443,986.34MM | IDR-2,091,905.54MM |
| Earnings Per Share** | IDR59.81 | IDR70.22 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.